GlassScriptPhysician profile
Deborah Tabachnick
NPI 1790074912
$13,362.55
in general payments reported to CMS, 2019-2025
9 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,350 · 2020: $585 · 2021: $903 · 2022: $2,792 · 2023: $2,841 · 2024: $301 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,233 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,232.89 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,566.73 | 2019-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve, Evoque |
| Medtronic Vascular, INC. | $2,831.67 | 2019 | |
| Medtronic, INC. | $2,644.76 | 2022-2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,507.55 | 2019-2023 | 2nd Gen Centrimag Primary Console |
| Baxter Healthcare | $1,500.00 | 2023 | |
| Abiomed | $176.86 | 2025 | |
| Davol INC. | $103.41 | 2025 | Avitene Ultrafoam |
| Philips North America LLC | $18.12 | 2025 | Labosys |
| Atricure, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Tabachnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.